Published in J Am Acad Dermatol on December 01, 1996
Oral hairy leukoplakia in HIV-positive patients. J Am Acad Dermatol (1998) 0.75
Other functions, other genes: alternative activation of antigen-presenting cells. Immunity (1999) 4.15
Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29
Human melanoma progression in skin reconstructs : biological significance of bFGF. Am J Pathol (2000) 2.23
Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J Immunol (1998) 2.17
Alternative versus classical activation of macrophages. Pathobiology (1999) 2.14
Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma. Lancet (1997) 1.98
Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. Br J Cancer (2009) 1.93
Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol (2001) 1.86
Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment. Br J Dermatol (1999) 1.79
Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol (2002) 1.71
Problems in defining cutoff points of continuous prognostic factors: example of tumor thickness in primary cutaneous melanoma. J Clin Epidemiol (1997) 1.69
The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J Invest Dermatol (2001) 1.67
The dermatoscopic pattern of clear-cell acanthoma resembles psoriasis vulgaris. Dermatology (2001) 1.66
Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors. Arch Dermatol (1996) 1.65
Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinations. Cancer (1997) 1.59
Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness. Br J Dermatol (2001) 1.56
Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol (1998) 1.54
Dermoscopic classification of atypical melanocytic nevi (Clark nevi). Arch Dermatol (2001) 1.49
Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment. Br J Dermatol (2007) 1.49
Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol (1992) 1.47
Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology (1997) 1.44
Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol (1999) 1.43
Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J (1997) 1.43
Basal cell carcinoma: histological classification and body-site distribution. Br J Dermatol (2006) 1.43
Intravascular coagulation necrosis of the skin associated with cryofibrinogenemia, diabetes mellitus, and cardiolipin autoantibodies. J Am Acad Dermatol (1991) 1.39
[Elective lymph node dissection in primary malignant melanoma]. Hautarzt (1996) 1.39
[Acute generalized exanthematous pustulosis, induced by nystatin]. Hautarzt (1998) 1.38
[Combination of interferon-alpha with cytostatic drugs: a potentially successful therapeutic approach in metastatic melanoma]. Hautarzt (1992) 1.38
[Merkel cell tumor of the skin]. Dtsch Med Wochenschr (1997) 1.38
Determinants of survival in patients with brain metastases from cutaneous melanoma. Br J Cancer (2010) 1.37
Outcomes of cryosurgery in keloids and hypertrophic scars. A prospective consecutive trial of case series. Arch Dermatol (1993) 1.36
Alterations of cell surfaces as a pathogenetic factor in psoriasis. Possible loss of contact inhibition of growth. Arch Dermatol (1973) 1.31
Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients. Br J Dermatol (2000) 1.29
Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma. Br J Cancer (1998) 1.28
Melanocytes in nevi and melanomas synthesize basement membrane and basement membrane-like material. An immunohistochemical and electron microscopic study including immunoelectron microscopy. J Cutan Pathol (2000) 1.27
Oral retinoids--present status. Br J Dermatol (1980) 1.26
Cytokine regulation of proliferation and ICAM-1 expression of human dermal microvascular endothelial cells in vitro. J Invest Dermatol (1992) 1.25
Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro. Immunology (1997) 1.24
Evidence for anti-inflammatory activities of oral synthetic retinoids: experimental findings and clinical experience. Br J Dermatol (1983) 1.24
Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus (1997) 1.23
13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J Invest Dermatol (2000) 1.21
Interferons in dermatology. J Am Acad Dermatol (1989) 1.19
Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis. Br J Cancer (2012) 1.19
Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge. Antimicrob Agents Chemother (2006) 1.18
Growth control of melanoma cells and melanocytes by cytokines. Recent Results Cancer Res (1995) 1.18
Clonal T-cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation. J Pathol (1999) 1.18
Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int J Cancer (1997) 1.17
Matting of hair: a multifactorial enigma. Dermatology (2000) 1.16
Expression of interleukin 10 in human melanoma. Br J Cancer (1994) 1.15
Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer (1995) 1.15
Dermal and epidermal types of erythema multiforme. A histopathologic study of 24 cases. Arch Dermatol (1974) 1.15
Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+3, MS-1+/-, 25F9-) in psoriatic dermis. Arch Dermatol Res (1996) 1.13
Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer (1995) 1.12
Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors. Cancer (1997) 1.12
Should adjuvant radiotherapy be recommended following resection of regional lymph node metastases of malignant melanomas? Br J Dermatol (2001) 1.12
Molecular events in melanoma development and progression. Front Biosci (1998) 1.10
Agreement between self-assessment of melanocytic nevi by patients and dermatologic examination. Am J Epidemiol (2000) 1.10
Hair destroying growth of Corynebacterium tenuis in the so-called trichomycosis axillaris. New findings from scanning electron microscopy. Arch Dermatol (1971) 1.09
Kaposi's sarcoma is an important risk factor for survival in HIV-infected patients independent of CD4+ cell count. AIDS (1999) 1.09
Microarchitecture is severely compromised but motor protein function is preserved in dystrophic mdx skeletal muscle. Biophys J (2010) 1.08
Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release. FEBS Lett (2000) 1.08
Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors. AIDS (1997) 1.07
The plasma unit membrane. Membrane mediated growth control and its failure in psoriasis. Br J Dermatol (1977) 1.07
Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine. J Biol Chem (1998) 1.06
Acute nongonococcal epididymitis. Aetiological and therapeutic aspects. Drugs (1987) 1.06
Sebocytes are the key regulators of androgen homeostasis in human skin. J Invest Dermatol (2001) 1.05
HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1. J Invest Dermatol (2001) 1.05
Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions. Br J Dermatol (2004) 1.04
Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol (1993) 1.04
Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy. Br J Dermatol (2005) 1.02
Non-specific lymphocyte transformation in vitro by nickel acetate. A possible source of errors in lymphocyte transformation test (LLT). J Invest Dermatol (1970) 1.02
Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG). Br J Cancer (2001) 1.02
Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype. J Invest Dermatol (1990) 1.02
[Acquired reactive perforating dermatosis. Successful treatment with allopurinol in 2 cases]. Hautarzt (1999) 1.01
[Beneficial effect of oral retinoid in psoriatic hyperproliferation. Autoradiographic studies on involved and non involved skin (author's transl)]. Arch Dermatol Res (1979) 1.00
Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients. Acta Derm Venereol (1997) 1.00
Kaposi's sarcoma in AIDS. Multicentric angioneoplasia in early skin lesions. Am J Dermatopathol (1987) 1.00
Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases. Br J Cancer (2003) 1.00
[Netherton's syndrome. Ichthyosis-like changes in the skin and trichorrhexis invaginata. Demonstration of pathologically changed cortex keratin in the hair]. Hautarzt (1971) 0.99
Electron microscopic study of bullous pemphigoid. Arch Dermatol (1972) 0.99
Tumor necrosis factor-alpha inhibits cell proliferation and induces class II antigens and cell adhesion molecules in cultured normal human keratinocytes in vitro. Arch Dermatol Res (1990) 0.98
Expression of vascular endothelial growth factor (VEGF) in various compartments of the human hair follicle. Arch Dermatol Res (1998) 0.98
Ultrastructure and cytochemistry of human cutaneous nerves. With special reference to the ultrastructural localization of the specific and nonspecific cholinesterases in human skin. J Invest Dermatol (1973) 0.98
Ultrastructural evidence suggesting an immunomodulatory activity of oral retinoid. Its effect on dermal components in psoriasis. Br J Dermatol (1981) 0.98
The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology (1998) 0.97
Intralesional rituximab for cutaneous B-cell lymphoma. Br J Dermatol (2001) 0.97
[Treatment of psoriasis using vitamin A, vitamin A acid and oral retinoids]. Hautarzt (1979) 0.97
Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol (2000) 0.96
Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study. Ann Oncol (2006) 0.96
Elephantiasis nostras verrucosa: beneficial effect of oral etretinate therapy. Br J Dermatol (1992) 0.96
Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Res (2000) 0.95
Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation. J Invest Dermatol (2001) 0.95
Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases. J Am Acad Dermatol (1991) 0.95
Fulminant metastatic calcinosis with cutaneous necrosis in a child with end-stage renal disease and tertiary hyperparathyroidism. Br J Dermatol (1996) 0.95
RNA isolation from human skin tissues for colorimetric differential display. J Biochem Biophys Methods (1998) 0.94
[Membrane defect as a basic disorder of the growth control mechanism in psoriasis pathogenetic concept and therapeutic consequences (author's transl)]. Dermatologica (1975) 0.94
Investigation of oestrogen receptors, sex steroids and soluble adhesion molecules in the progression of malignant melanoma. Melanoma Res (1997) 0.94